Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes
Benign prostatic hyperplasia (BPH) is one of the most common diseases affecting aging men with limited therapeutic options. In this study, the authors describe the molecular characterization of BPH performing genomic, transcriptomic and epigenetic analysis of 18 BPH cases.
Enregistré dans:
Auteurs principaux: | Deli Liu, Jonathan E. Shoag, Daniel Poliak, Ramy S. Goueli, Vaishali Ravikumar, David Redmond, Aram Vosoughi, Jacqueline Fontugne, Heng Pan, Daniel Lee, Domonique Thomas, Keyan Salari, Zongwei Wang, Alessandro Romanel, Alexis Te, Richard Lee, Bilal Chughtai, Aria F. Olumi, Juan Miguel Mosquera, Francesca Demichelis, Olivier Elemento, Mark A. Rubin, Andrea Sboner, Christopher E. Barbieri |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e8baf4a938944f0fbc66a64df0469d3e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Multiplatform Physiologic and Metabolic Phenotyping Reveals Microbial Toxicity
par: Jingwei Cai, et autres
Publié: (2018) -
Identification and quantification of honeybee venom constituents by multiplatform metabolomics
par: Agnieszka Klupczynska, et autres
Publié: (2020) -
The dawning era of personalized medicine exposes a gap in medical education.
par: Keyan Salari
Publié: (2009) -
Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningioma
par: Stephen T. Magill, et autres
Publié: (2020) -
Prognostic biomarkers of Parkinson’s disease in the Spanish EPIC cohort: a multiplatform metabolomics approach
par: Carolina Gonzalez-Riano, et autres
Publié: (2021)